All companies
Visit website
XRHealth
OperatingXRHealth, Inc.
Healthcare · Technology · Founded 2020
On-demand virtual care reinvented
Post-money valuation ⓘ
$81.3M
As of Feb 2022 · from XRHealth Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$215,112
Across 1 round since 2021
Latest share price
$25.63
XRHealth Common Stock 1 offering price
Financials
FY2019–FY2021 · from SEC filings · hover any figure for its source$144K
−$2.8M
2019
$399K
−$7.4M
2020
$1.5M
−$8.4M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
Income statement
Revenue
$143,955
$399,475
$1,505,322
Cost of goods sold
$52,431
$221,914
$614,664
Gross margin
64%
44%
59%
Net income
-$2,816,081
-$7,415,706
-$8,446,076
Taxes paid
$0
$0
$0
Balance sheet
Cash
$1,915,708
$2,481,903
$1,538,110
Accounts receivable
$99
$63,666
$301,719
Total assets
$2,307,873
$5,023,789
$8,552,997
Short-term debt
$23,630
$0
$3,497,494
Long-term debt
$224,443
$750,000
$3,459,249
Total liabilities
$248,073
$750,000
$6,956,743
Other
Headcount
—
75
75
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$81.3M
post-money
XRHealth Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $215.1K / $1.1MInvestors 111Post-money $81.3M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 5 annual reports (FY2021–FY2025)
111 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001892473Share price $25.63
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.